tiprankstipranks
Trending News
More News >
InnoCan Pharma (INNPF)
OTHER OTC:INNPF
US Market
Advertisement

InnoCan Pharma (INNPF) Ratios

Compare
13 Followers

InnoCan Pharma Ratios

INNPF's free cash flow for Q1 2025 was $0.91. For the 2025 fiscal year, INNPF's free cash flow was decreased by $ and operating cash flow was
lt;0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.08 2.68 9.41 3.51 0.54
Quick Ratio
2.95 1.99 7.86 3.37 0.48
Cash Ratio
2.42 1.53 6.77 3.10 0.29
Solvency Ratio
-0.16 -1.83 -5.13 -2.81 -1.91
Operating Cash Flow Ratio
-0.18 -1.54 -8.30 -1.86 -0.46
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 6.78M$ 4.25M$ 6.13M$ 8.96M$ -3.66M
Leverage Ratios
Debt-to-Assets Ratio
0.12 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.28 <0.01 <0.01 <0.01 -0.01
Debt-to-Capital Ratio
0.22 <0.01 <0.01 <0.01 -0.01
Long-Term Debt-to-Capital Ratio
0.22 0.00 0.00 0.00 0.00
Financial Leverage Ratio
2.31 1.69 1.09 1.39 -1.20
Debt Service Coverage Ratio
13.00 0.00 -1.93K -769.54 -2.89
Interest Coverage Ratio
56.75 0.00 -3.13K -575.38 -0.90
Debt to Market Cap
0.03 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 0.03
Net Debt to EBITDA
-3.86 1.02 1.28 1.10 0.23
Profitability Margins
Gross Profit Margin
89.61%87.71%82.34%61.73%37.50%
EBIT Margin
4.19%-27.85%-151.86%-5141.84%-124312.50%
EBITDA Margin
4.31%-27.60%-150.49%-5119.90%-123812.50%
Operating Profit Margin
1.49%27.85%-244.86%-3816.33%-59062.50%
Pretax Profit Margin
7.13%-29.54%-151.93%-5148.47%-124412.50%
Net Profit Margin
-2.13%-34.41%-151.97%-5132.65%-189762.50%
Continuous Operations Profit Margin
3.16%-31.10%-151.97%-5148.47%-124412.50%
Net Income Per EBT
-29.88%116.51%100.03%99.69%152.53%
EBT Per EBIT
478.41%-106.07%62.05%134.91%210.65%
Return on Assets (ROA)
-6.00%-67.72%-55.75%-80.00%-350.28%
Return on Equity (ROE)
-13.09%-114.55%-60.82%-111.10%420.88%
Return on Capital Employed (ROCE)
5.54%86.49%-100.34%-83.01%131.03%
Return on Invested Capital (ROIC)
2.46%90.63%-100.14%-82.75%201.93%
Return on Tangible Assets
-6.00%-67.72%-55.75%-80.00%-350.28%
Earnings Yield
-1.46%-7.82%-9.85%-7.08%-35.64%
Efficiency Ratios
Receivables Turnover
28.10 54.85 41.27 0.00 <0.01
Payables Turnover
17.78 14.99 4.76 1.42 <0.01
Inventory Turnover
1.07 0.96 0.40 0.15 0.01
Fixed Asset Turnover
284.72 100.42 26.11 3.63 0.14
Asset Turnover
2.82 1.97 0.37 0.02 <0.01
Working Capital Turnover Ratio
4.06 2.62 0.34 0.07 >-0.01
Cash Conversion Cycle
333.23 362.09 845.44 2.22K 44.43K
Days of Sales Outstanding
12.99 6.65 8.84 0.00 51.51K
Days of Inventory Outstanding
340.77 379.78 913.31 2.48K 31.39K
Days of Payables Outstanding
20.53 24.35 76.71 257.93 38.47K
Operating Cycle
353.76 386.44 922.15 2.48K 82.90K
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 -0.02 -0.02 -0.03 -0.02
Free Cash Flow Per Share
>-0.01 -0.02 -0.02 -0.03 -0.02
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
1.04 1.01 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
-25.78 -84.87 -233.35 -161.68 0.00
Capital Expenditure Coverage Ratio
-25.78 -84.87 -233.35 -161.68 0.00
Operating Cash Flow Coverage Ratio
-0.36 -118.30 -178.44 -6.63K -97.03
Operating Cash Flow to Sales Ratio
-0.02 -0.29 -2.37 -33.82 -460.88
Free Cash Flow Yield
-1.08%-6.58%-15.43%-4.70%-8.66%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-68.49 -12.78 -10.15 -14.12 -2.81
Price-to-Sales (P/S) Ratio
1.47 4.40 15.43 724.58 5.32K
Price-to-Book (P/B) Ratio
9.50 14.64 6.18 15.68 -11.81
Price-to-Free Cash Flow (P/FCF) Ratio
-92.88 -15.21 -6.48 -21.29 -11.55
Price-to-Operating Cash Flow Ratio
-95.79 -15.39 -6.51 -21.42 -11.55
Price-to-Earnings Growth (PEG) Ratio
-1.05 -0.74 0.16 0.27 -0.01
Price-to-Fair Value
9.50 14.64 6.18 15.68 -11.81
Enterprise Value Multiple
30.24 -14.91 -8.98 -13.05 -4.07
Enterprise Value
39.72M 56.22M 34.57M 130.97M 40.30M
EV to EBITDA
30.25 -14.91 -8.98 -13.05 -4.07
EV to Sales
1.30 4.12 13.51 668.22 5.04K
EV to Free Cash Flow
-82.41 -14.23 -5.67 -19.64 -10.93
EV to Operating Cash Flow
-85.60 -14.40 -5.70 -19.76 -10.93
Tangible Book Value Per Share
0.02 0.02 0.03 0.04 -0.02
Shareholders’ Equity Per Share
0.02 0.02 0.03 0.04 -0.02
Tax and Other Ratios
Effective Tax Rate
0.56 -0.05 >-0.01 <0.01 -0.53
Revenue Per Share
0.10 0.05 0.01 <0.01 <0.01
Net Income Per Share
>-0.01 -0.02 -0.02 -0.04 -0.09
Tax Burden
-0.30 1.17 1.00 1.00 1.53
Interest Burden
1.70 1.06 1.00 1.00 1.00
Research & Development to Revenue
0.04 0.13 0.60 7.14 170.63
SG&A to Revenue
0.12 0.23 1.56 18.91 362.38
Stock-Based Compensation to Revenue
0.03 0.06 0.38 11.04 65.88
Income Quality
-0.48 0.83 1.56 0.66 0.37
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis